{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:32:41Z","timestamp":1793143961866,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"44","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,11,18]]},"DOI":"10.1038\/s41388-026-03995-3","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:00:17Z","timestamp":1790784017000},"page":"4843-4858","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ACTB promotes ESCC progression by regulating the AKT\u2013mTOR signaling pathway through an m6A-dependent mechanism"],"prefix":"10.1038","volume":"45","author":[{"given":"Yunshan","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxia","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canyang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0645-5463","authenticated-orcid":false,"given":"Fang","family":"Shaobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxue","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoling","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"3995_CR1","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1053\/j.gastro.2017.08.023","volume":"154","author":"CC Abnet","year":"2018","unstructured":"Abnet CC, Arnold M, Wei WQ. Epidemiology of esophageal squamous cell carcinoma. Gastroenterology. 2018;154:360\u201373.","journal-title":"Gastroenterology"},{"key":"3995_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10552-014-0485-0","volume":"26","author":"S Giri","year":"2015","unstructured":"Giri S, Pathak R, Aryal MR, Karmacharya P, Bhatt VR, Martin MG. Incidence trend of esophageal squamous cell carcinoma: an analysis of Surveillance Epidemiology, and End Results (SEER) database. Cancer Causes Control. 2015;26:159\u201361.","journal-title":"Cancer Causes Control"},{"key":"3995_CR3","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.jamcollsurg.2012.07.006","volume":"215","author":"M Worni","year":"2012","unstructured":"Worni M, Martin J, Gloor B, Pietrobon R, D\u2019Amico TA, Akushevich I, et al. Does surgery improve outcomes for esophageal squamous cell carcinoma? An analysis using the surveillance epidemiology and end results registry from 1998 to 2008. J Am Coll Surg. 2012;215:643\u201351.","journal-title":"J Am Coll Surg"},{"key":"3995_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101051","volume":"14","author":"R Suresh","year":"2021","unstructured":"Suresh R, Diaz RJ. The remodelling of actin composition as a hallmark of cancer. Transl Oncol. 2021;14:101051.","journal-title":"Transl Oncol"},{"key":"3995_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4161\/nucl.22798","volume":"4","author":"P Percipalle","year":"2013","unstructured":"Percipalle P. Co-transcriptional nuclear actin dynamics. Nucleus. 2013;4:43\u201352.","journal-title":"Nucleus"},{"key":"3995_CR6","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.tcb.2013.10.007","volume":"24","author":"P Kapoor","year":"2014","unstructured":"Kapoor P, Shen X. Mechanisms of nuclear actin in chromatin-remodeling complexes. Trends Cell Biol. 2014;24:238\u201346.","journal-title":"Trends Cell Biol"},{"key":"3995_CR7","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aay6515","volume":"6","author":"M Wei","year":"2020","unstructured":"Wei M, Fan X, Ding M, Li R, Shao S, Hou Y, et al. Nuclear actin regulates inducible transcription by enhancing RNA polymerase II clustering. Sci Adv. 2020;6:eaay6515.","journal-title":"Sci Adv"},{"key":"3995_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2025.1561799","volume":"16","author":"L Wen","year":"2025","unstructured":"Wen L, Fu J, Wang Z, Xie R, Tang S, Yu L, et al. Regulatory mechanisms of m6A RNA methylation in esophageal cancer: a comprehensive review. Front Genet. 2025;16:1561799.","journal-title":"Front Genet"},{"key":"3995_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-024-10294-2","volume":"25","author":"D Zhang","year":"2024","unstructured":"Zhang D, Fu W, Zhu S, Pan Y, Li R. RNA methylation patterns, immune characteristics, and autophagy-related mechanisms mediated by N6-methyladenosine (m6A) regulatory factors in venous thromboembolism. BMC Genomics. 2024;25:403.","journal-title":"BMC Genomics"},{"key":"3995_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13317-9","volume":"10","author":"Y Mao","year":"2019","unstructured":"Mao Y, Dong L, Liu XM, Guo J, Ma H, Shen B, et al. m(6)A in mRNA coding regions promotes translation via the RNA helicase-containing YTHDC2. Nat Commun. 2019;10:5332.","journal-title":"Nat Commun"},{"key":"3995_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05293-6","volume":"22","author":"X Wu","year":"2024","unstructured":"Wu X, Chen H, Li K, Zhang H, Li K, Tan H. The biological function of the N6-Methyladenosine reader YTHDC2 and its role in diseases. J Transl Med. 2024;22:490.","journal-title":"J Transl Med"},{"key":"3995_CR12","doi-asserted-by":"crossref","unstructured":"Morgos DT, Stefani C, Miricescu D, Greabu M, Stanciu S, Nica S, et al. Targeting PI3K\/AKT\/mTOR and MAPK Signaling Pathways in Gastric Cancer. Int J Mol Sci 2024;25:1\u201326.","DOI":"10.3390\/ijms25031848"},{"key":"3995_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Lam HY, Yap KCH, Jacot W, Jones RH, et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 2023;22:138.","journal-title":"Mol Cancer"},{"key":"3995_CR14","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.canlet.2007.01.026","volume":"253","author":"G Hou","year":"2007","unstructured":"Hou G, Xue L, Lu Z, Fan T, Tian F, Xue Y. An activated mTOR\/p70S6K signaling pathway in esophageal squamous cell carcinoma cell lines and inhibition of the pathway by rapamycin and siRNA against mTOR. Cancer Lett. 2007;253:236\u201348.","journal-title":"Cancer Lett"},{"key":"3995_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.852383","volume":"12","author":"Q Luo","year":"2022","unstructured":"Luo Q, Du R, Liu W, Huang G, Dong Z, Li X. PI3K\/Akt\/mTOR Signaling Pathway: Role in Esophageal Squamous Cell Carcinoma, Regulatory Mechanisms and Opportunities for Targeted Therapy. Front Oncol. 2022;12:852383.","journal-title":"Front Oncol"},{"key":"3995_CR16","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.3748\/wjg.v30.i20.2638","volume":"30","author":"YX Zhao","year":"2024","unstructured":"Zhao YX, Zhao HP, Zhao MY, Yu Y, Qi X, Wang JH, et al. Latest insights into the global epidemiological features, screening, early diagnosis and prognosis prediction of esophageal squamous cell carcinoma. World J Gastroenterol. 2024;30:2638\u201356.","journal-title":"World J Gastroenterol"},{"key":"3995_CR17","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1038\/ncb3641","volume":"19","author":"C Baarlink","year":"2017","unstructured":"Baarlink C, Plessner M, Sherrard A, Morita K, Misu S, Virant D, et al. A transient pool of nuclear F-actin at mitotic exit controls chromatin organization. Nat Cell Biol. 2017;19:1389\u201399.","journal-title":"Nat Cell Biol"},{"key":"3995_CR18","doi-asserted-by":"publisher","DOI":"10.1017\/S1462399411002109","volume":"14","author":"SM Schultze","year":"2012","unstructured":"Schultze SM, Hemmings BA, Niessen M, Tschopp O. PI3K\/AKT, MAPK and AMPK signalling: protein kinases in glucose homeostasis. Expert Rev Mol Med. 2012;14:e1.","journal-title":"Expert Rev Mol Med"},{"key":"3995_CR19","doi-asserted-by":"crossref","unstructured":"Stefani C, Miricescu D, Stanescu S II, Nica RI, Greabu M, et al. Growth Factors, PI3K\/AKT\/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now? Int J Mol Sci 2021;22:1\u201324.","DOI":"10.3390\/ijms221910260"},{"key":"3995_CR20","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/35077213","volume":"411","author":"GI Evan","year":"2001","unstructured":"Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001;411:342\u20138.","journal-title":"Nature"},{"key":"3995_CR21","doi-asserted-by":"crossref","unstructured":"Hohmann T, Dehghani F The Cytoskeleton-A Complex Interacting Meshwork. Cells 2019;8:1\u201355.","DOI":"10.3390\/cells8040362"},{"key":"3995_CR22","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1152\/physrev.00021.2007","volume":"88","author":"C Le Clainche","year":"2008","unstructured":"Le Clainche C, Carlier MF. Regulation of actin assembly associated with protrusion and adhesion in cell migration. Physiol Rev. 2008;88:489\u2013513.","journal-title":"Physiol Rev"},{"key":"3995_CR23","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.devcel.2010.02.017","volume":"18","author":"SL Gupton","year":"2010","unstructured":"Gupton SL, Gertler FB. Integrin signaling switches the cytoskeletal and exocytic machinery that drives neuritogenesis. Dev Cell. 2010;18:725\u201336.","journal-title":"Dev Cell"},{"key":"3995_CR24","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.bbamcr.2006.07.001","volume":"1773","author":"H Yamaguchi","year":"2007","unstructured":"Yamaguchi H, Condeelis J. Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta. 2007;1773:642\u201352.","journal-title":"Biochim Biophys Acta"},{"key":"3995_CR25","doi-asserted-by":"publisher","first-page":"4512","DOI":"10.1523\/JNEUROSCI.0333-09.2009","volume":"29","author":"S Stern","year":"2009","unstructured":"Stern S, Debre E, Stritt C, Berger J, Posern G, Knoll B. A nuclear actin function regulates neuronal motility by serum response factor-dependent gene transcription. J Neurosci. 2009;29:4512\u20138.","journal-title":"J Neurosci"},{"key":"3995_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2019.109479","volume":"67","author":"Y Li","year":"2020","unstructured":"Li Y, Ma H, Shi C, Feng F, Yang L. Mutant ACTB mRNA 3\u2019-UTR promotes hepatocellular carcinoma development by regulating miR-1 and miR-29a. Cell Signal. 2020;67:109479.","journal-title":"Cell Signal"},{"key":"3995_CR27","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10388-022-00939-0","volume":"19","author":"M Ito","year":"2022","unstructured":"Ito M, Hiwasa T, Yajima S, Suzuki T, Oshima Y, Nanami T, et al. Low anti-CFL1 antibody with high anti-ACTB antibody is a poor prognostic factor in esophageal squamous cell carcinoma. Esophagus. 2022;19:617\u201325.","journal-title":"Esophagus"},{"key":"3995_CR28","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020105977","volume":"40","author":"PC He","year":"2021","unstructured":"He PC, He C. m(6) A RNA methylation: from mechanisms to therapeutic potential. EMBO J. 2021;40:e105977.","journal-title":"EMBO J"},{"key":"3995_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1109-9","volume":"18","author":"L He","year":"2019","unstructured":"He L, Li H, Wu A, Peng Y, Shu G, Yin G. Functions of N6-methyladenosine and its role in cancer. Mol Cancer. 2019;18:176.","journal-title":"Mol Cancer"},{"key":"3995_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216420","volume":"576","author":"L Chen","year":"2023","unstructured":"Chen L, Sun K, Qin W, Huang B, Wu C, Chen J, et al. LIMK1 m(6)A-RNA methylation recognized by YTHDC2 induces 5-FU chemoresistance in colorectal cancer via endoplasmic reticulum stress and stress granule formation. Cancer Lett. 2023;576:216420.","journal-title":"Cancer Lett"},{"key":"3995_CR31","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s12010-023-04540-8","volume":"196","author":"G Zhou","year":"2024","unstructured":"Zhou G, Wang S. YTHDC2 Retards Cell Proliferation and Triggers Apoptosis in Papillary Thyroid Cancer by Regulating CYLD-Mediated Inactivation of Akt Signaling. Appl Biochem Biotechnol. 2024;196:588\u2013603.","journal-title":"Appl Biochem Biotechnol"},{"key":"3995_CR32","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.7150\/ijbs.95595","volume":"20","author":"JR Guo","year":"2024","unstructured":"Guo JR, He KY, Yuan JL, An W, Yin WT, Li QT, et al. HMGA1 sensitizes esophageal squamous cell carcinoma to mTOR inhibitors through the ETS1-FKBP12 axis. Int J Biol Sci. 2024;20:2640\u201357.","journal-title":"Int J Biol Sci"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03995-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03995-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03995-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:03:12Z","timestamp":1793142192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03995-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":32,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2026,11,18]]}},"alternative-id":["3995"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03995-3","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All methods involving human participants were performed in accordance with the Declaration of Helsinki and the relevant institutional guidelines and regulations. The use of human ESCC tissues for patient-derived organoid experiments was approved by the Ethics Committee of Affiliated Cancer Hospital of Zhengzhou University (approval no. 2023-KY-0156-001). All animal experiments were approved by the Ethics Committee of China-US (Henan) Hormel Cancer Institute (approval no. CUHCI2019072) and were performed in accordance with the approved protocols and relevant institutional, national, and international guidelines and regulations, including the Regulations for the Administration of Laboratory Animals and the Ethical Principles for the Use of Laboratory Animals.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}